Skip to main content
. 2021 Feb 19;15(2):e0009128. doi: 10.1371/journal.pntd.0009128

Table 7. Comparison of Complication Frequencies Between the Steroid and Non-Steroid Groups in Patients with SFTS after Propensity Score Matching.

Non-Steroid (n = 56) Steroid (n = 56)
Variables n(%) n(%) P Valuea
Complication, total 16 (28.6) 35 (62.5) < .001
    Meningoencephalitis 0 (0.0) 5 (8.9) N/A
    Mechanical ventilation 7 (12.5) 19 (33.9) .007
    Arrhythmia 1 (1.8) 6 (10.7) .113
    Pneumonia 1 (1.8) 8 (14.3) .032
    Seizure 0 (0.0) 2 (3.6) .495
    Rhabdomyolysis 2 (3.6) 0 (0.0) N/A
    MOD 0 (0.0) 1 (1.8) N/A
    Septic shock or sepsis 4 (7.1) 7 (12.5) .341
    Acute kidney injury 5 (8.9) 5 (8.9) 1.000
    G-I bleeding 0 (0.0) 1 (1.8) N/A
    HLH 0 (0.0) 3 (5.4) N/A
    DIC 0 (0.0) 3 (5.4) N/A
    Others b 8 (14.3) 2 (3.6) .047

Abbreviation: DIC, disseminated intravascular coagulation; G-I, gastro-intestinal; HLH, hemophagocytic lymphohistiocytosis; MOD, multiple organ dysfunction; N/A, not available.

a Analysis using Chi-square test or Fisher’s exact test.

b Other complications included acute cerebral infarction, acute respiratory distress syndrome, aspiration pneumonia, azotaemia, infectious mononucleosis, intracranial haemorrhage, metabolic encephalopathy, respiratory failure, and toxic hepatitis.